215 related articles for article (PubMed ID: 10595935)
1. Psoriasin (S100A7) expression and invasive breast cancer.
Al-Haddad S; Zhang Z; Leygue E; Snell L; Huang A; Niu Y; Hiller-Hitchcock T; Hole K; Murphy LC; Watson PH
Am J Pathol; 1999 Dec; 155(6):2057-66. PubMed ID: 10595935
[TBL] [Abstract][Full Text] [Related]
2. Psoriasin (S100A7) expression is associated with poor outcome in estrogen receptor-negative invasive breast cancer.
Emberley ED; Niu Y; Njue C; Kliewer EV; Murphy LC; Watson PH
Clin Cancer Res; 2003 Jul; 9(7):2627-31. PubMed ID: 12855640
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor-beta regulates psoriasin (S100A7) in human breast cancer.
Skliris GP; Lewis A; Emberley E; Peng B; Weebadda WK; Kemp A; Davie JR; Shiu RP; Watson PH; Murphy LC
Breast Cancer Res Treat; 2007 Jul; 104(1):75-85. PubMed ID: 17009105
[TBL] [Abstract][Full Text] [Related]
4. Psoriasin interacts with Jab1 and influences breast cancer progression.
Emberley ED; Niu Y; Leygue E; Tomes L; Gietz RD; Murphy LC; Watson PH
Cancer Res; 2003 Apr; 63(8):1954-61. PubMed ID: 12702588
[TBL] [Abstract][Full Text] [Related]
5. RanBPM interacts with psoriasin in vitro and their expression correlates with specific clinical features in vivo in breast cancer.
Emberley ED; Gietz RD; Campbell JD; HayGlass KT; Murphy LC; Watson PH
BMC Cancer; 2002 Nov; 2():28. PubMed ID: 12421467
[TBL] [Abstract][Full Text] [Related]
6. S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situ of the breast.
Emberley ED; Alowami S; Snell L; Murphy LC; Watson PH
Breast Cancer Res; 2004; 6(4):R308-15. PubMed ID: 15217497
[TBL] [Abstract][Full Text] [Related]
7. Psoriasin expression in mammary epithelial cells in vitro and in vivo.
Enerbäck C; Porter DA; Seth P; Sgroi D; Gaudet J; Weremowicz S; Morton CC; Schnitt S; Pitts RL; Stampl J; Barnhart K; Polyak K
Cancer Res; 2002 Jan; 62(1):43-7. PubMed ID: 11782356
[TBL] [Abstract][Full Text] [Related]
8. A putative role for psoriasin in breast tumor progression.
Krop I; März A; Carlsson H; Li X; Bloushtain-Qimron N; Hu M; Gelman R; Sabel MS; Schnitt S; Ramaswamy S; Kleer CG; Enerbäck C; Polyak K
Cancer Res; 2005 Dec; 65(24):11326-34. PubMed ID: 16357139
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of psoriasin messenger RNA between in situ and invasive human breast carcinoma.
Leygue E; Snell L; Hiller T; Dotzlaw H; Hole K; Murphy LC; Watson PH
Cancer Res; 1996 Oct; 56(20):4606-9. PubMed ID: 8840971
[TBL] [Abstract][Full Text] [Related]
10. Psoriasin (S100A7) is significantly up-regulated in human epithelial skin tumours.
Moubayed N; Weichenthal M; Harder J; Wandel E; Sticherling M; Gläser R
J Cancer Res Clin Oncol; 2007 Apr; 133(4):253-61. PubMed ID: 17136347
[TBL] [Abstract][Full Text] [Related]
11. Loss of ICAM-1 signaling induces psoriasin (S100A7) and MUC1 in mammary epithelial cells.
Petersson S; Shubbar E; Yhr M; Kovacs A; Enerbäck C
Breast Cancer Res Treat; 2011 Jan; 125(1):13-25. PubMed ID: 20217214
[TBL] [Abstract][Full Text] [Related]
12. Psoriasin is aberrantly expressed in human breast cancer and is related to clinical outcomes.
Jiang WG; Watkins G; Douglas-Jones A; Mansel RE
Int J Oncol; 2004 Jul; 25(1):81-5. PubMed ID: 15201992
[TBL] [Abstract][Full Text] [Related]
13. Psoriasin (S100A7) expression is altered during skin tumorigenesis.
Alowami S; Qing G; Emberley E; Snell L; Watson PH
BMC Dermatol; 2003 Feb; 3():1. PubMed ID: 12600274
[TBL] [Abstract][Full Text] [Related]
14. Cluster analysis of S100 gene expression and genes correlating to psoriasin (S100A7) expression at different stages of breast cancer development.
Carlsson H; Petersson S; Enerbäck C
Int J Oncol; 2005 Dec; 27(6):1473-81. PubMed ID: 16273201
[TBL] [Abstract][Full Text] [Related]
15. S100A7 (psoriasin) influences immune response genes in human breast cancer.
Mandal S; Curtis L; Pind M; Murphy LC; Watson PH
Exp Cell Res; 2007 Aug; 313(14):3016-25. PubMed ID: 17560571
[TBL] [Abstract][Full Text] [Related]
16. Expression analysis of the mouse S100A7/psoriasin gene in skin inflammation and mammary tumorigenesis.
Webb M; Emberley ED; Lizardo M; Alowami S; Qing G; Alfia'ar A; Snell-Curtis LJ; Niu Y; Civetta A; Myal Y; Shiu R; Murphy LC; Watson PH
BMC Cancer; 2005 Feb; 5():17. PubMed ID: 15717926
[TBL] [Abstract][Full Text] [Related]
17. The clinical significance of Psoriasin for non-small cell lung cancer patients and its biological impact on lung cancer cell functions.
Hu M; Ye L; Ruge F; Zhi X; Zhang L; Jiang WG
BMC Cancer; 2012 Dec; 12():588. PubMed ID: 23228205
[TBL] [Abstract][Full Text] [Related]
18. Human hair follicle epithelium has an antimicrobial defence system that includes the inducible antimicrobial peptide psoriasin (S100A7) and RNase 7.
Reithmayer K; Meyer KC; Kleditzsch P; Tiede S; Uppalapati SK; Gläser R; Harder J; Schröder JM; Paus R
Br J Dermatol; 2009 Jul; 161(1):78-89. PubMed ID: 19416233
[TBL] [Abstract][Full Text] [Related]
19. Psoriasin (S100A7) is a positive regulator of survival and invasion of prostate cancer cells.
Ye L; Sun PH; Martin TA; Sanders AJ; Mason MD; Jiang WG
Urol Oncol; 2013 Nov; 31(8):1576-83. PubMed ID: 22694938
[TBL] [Abstract][Full Text] [Related]
20. S100A7 (Psoriasin), highly expressed in ductal carcinoma in situ (DCIS), is regulated by IFN-gamma in mammary epithelial cells.
Petersson S; Bylander A; Yhr M; Enerbäck C
BMC Cancer; 2007 Nov; 7():205. PubMed ID: 17986321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
